ImmunoGen’s Multi-Target License and Option Agreement with ImmunoBiochem

Pietro Martinoia North America Legal Chronicle
Tagged:

Ropes & Gray represented ImmunoGen in the deal.ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the discovery…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here